Index colonoscopy schedules for EUQA cohort and BSG/ACPGBI/PHE virtual model
Index colonoscopy | First surveillance colonoscopy | |||||
EUQA 2013 | BSG/ACPGBI/PHE 2019 | P value* | EUQA 2013 | BSG/ACPGBI/PHE 2019 | P value* | |
Total | 775 | 775 | 219 | 152 | ||
Cancer MDT | 36 | 36 | 1.0000 | 1 | 2 | 0.5702 |
Symptomatic service | 12 | 12 | 1.0000 | 0 | 0 | |
6 month | 31 | 31 | 1.0000 | 5 | 1 | 0.4074 |
+ 1 year | 22 | 13 | 0.1706 | 3 | 1 | 0.6473 |
+ 3 years | 8 | 17 | 0.1049 | 2 | 0 | 0.5150 |
+ Surgery | 1 | 1 | 1.0000 | 0 | 0 | 1.0000 |
1 year | 92 | 1 | <0.0001 | 16 | 3 | 0.0290 |
3 year | 169 | 163 | 0.7569 | 197 | 24 | <0.0001 |
5 year | n/a | n/a | n/a | n/a | ||
NCRCS programme | 435 | 532 | <0.0001 | 0 | 122 | <0.0001 |
Total colonoscopies scheduled | 291 | 194 | <0.0001 | 218 | 27 | <0.0001 |
Boldface used to highlight significant p values.
*Two-tailed p value from Fisher’s test.
BSG/ACPGBI/PHE, British Society of Gastroenterology/Association of Coloproctology of Great Britain and Ireland/Public Health England; EUQA, European Guidelines for Quality Assurance in Colorectal Cancer Screening and Diagnosis; MDT, multidisciplinary meeting; NCRCS, national colorectal cancer screening .